Greg Behar, Recipharm CEO

Re­ci­pharm hits record rev­enue for 2024, eyes GLP-1 con­tracts for growth 

Greg Be­har’s shake­up of Re­ci­pharm is pay­ing off in his first year as CEO.

The CD­MO re­port­ed record-high rev­enues on Fri­day, and the com­pa­ny ex­pects …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.